Cover Image
市場調查報告書

NIPT (非侵入性產前遺傳學的診斷)的全球市場:市場規模 (以金額、數量為準)的分析

Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020

出版商 iGate Research Pvt Ltd 商品編碼 360457
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
Back to Top
NIPT (非侵入性產前遺傳學的診斷)的全球市場:市場規模 (以金額、數量為準)的分析 Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020
出版日期: 2015年06月02日 內容資訊: 英文 107 Pages
簡介

所謂NIPT (Noninvasive prenatal testing:非侵入性產前遺傳學的診斷) ,是為了診斷胎兒的染色體非整倍體 (染色體異常) 的最新技術,從孕婦採集的血液分析胎兒DNA的手法。從2011年的登場以來,實施了許多孕婦NIPT,預期今後檢查數量、市場規模也將擴大。另一方面,因為與類似的檢驗方法的競爭也很激烈,各企業積極地推動擴大檢驗機會。

本報告提供全球NIPT (產前診斷) 市場現況與未來展望相關分析,關於NIPT概要,及代表性的染色體異常的概要、趨勢,整體市場規模、佔有率的變化與預測 (過去4年、今後6年份),各檢驗手法的特徵與市場趨勢預測,主要的推動及阻礙市場要素,近幾年的資本交易的動向,今後的市場成長可能性、方向性等調查評估。

第1章 摘要整理

第2章 全球NIPT (非侵入性產前遺傳學的診斷) 市場分析 (總計9年份)

  • 市場規模與其預測 (以金額為準)
  • 市場規模與其預測 (以數量為準)

第3章 全球NIPT市場佔有率分析 (總計9年份)

  • 市場佔有率與其預測 (以金額為準)
  • 市場佔有率與其預測 (以數量為準)

第4章 與主要染色體異常其發病率分析

  • 唐氏症
  • 艾德華茲症候群
  • 巴陶氏症
  • 透納氏症
  • 柯林菲特氏症
  • 雅各氏症
  • 三倍X染色體症候群

第5章 全球NIPT市場:各種檢驗比較分析

第6章 全球NIPT市場:各檢驗手法的市場規模 (總計9年份)

  • Bambni Test
    • 市場收益額與其預測
    • 檢查數量與其預測
  • Harmony Prenatal Test
  • informaSeq Test
  • MaterniT21 PLUS Test
  • NIFTY (Non-invasive Fetal Trisomy) Test
  • Panorama Prenatal Test
  • PrenaTest
  • Verifi Prenatal Test
  • VisibiliT Test
  • NIPD Test

第7章 全球NIPT市場:近幾年主要的資本交易

  • 產業合作
  • 產業聯盟
  • 流通協定
  • 許可證協定
  • 壟斷的契約
  • 企業合併、收購 (M&A)
  • 創業投資投資

第8章 NIPT的普及情形與課題

  • 已開發國家的普及情形與課題
    • 在臨床方面的課題
    • 道德性課題
    • 在法律方面、規定方面的課題
  • 在發展中國家、中等收入國家的普及情形與課題

第9章 全球NIPT市場推動因素

  • 嬰幼兒的唐氏症發病率的上升
  • 平均生產年齡的上升,和先天性缺損的風險上升

第10章 全球NIPT市場課題

  • 法規的指南和道德性障礙
  • NIPT相關規定事項

圖表一覽

目錄

Noninvasive prenatal testing (NIPT) is an advancement in the detection of fetal chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant woman. Since its introduction to clinical practice in 2011, NIPT has quickly spread across the globe. Hundreds of thousands of pregnant women have used these noninvasive prenatal tests since they appeared on the market in 2011. The global market for NIPT is growing rapidly; it has been projected to grow at a double digit growth rate during the period 2015 - 2020. The competition in the NIPT market landscape is fierce and the companies are aggressively looking to push their test volume.

Global - Non-Invasive Prenatal Testing (NIPT) Market Analysis: MaterniT21 PLUS is the most popular test in NIPT market but it is facing high competition from other tests and also from introduction of newer tests like informaSeq and VisibiliT prental tests. Harmony prenatal test and Verifi test are competing closely to grab a handsome share of the total NIPT market. Panorama test is anticipated to emerge as one of the leading test in the Global NIPT market by the year 2020. BambniTest and NIFTY tests are also looking to capture maximum pie of the Global NIPT market.

Global - Non-Invasive Prenatal Testing (NIPT) Volume Analysis: In the Global NIPT Test Volume, NIFTY Test captured the majority share followed by Harmony in the year 2014. MaterniT21 PLUS and BambniTest accounted for XXX% and XXX% share of the overall NIPT volume respectively in 2014. Panorama and Verifi test volume share is also expected to rise during the forecasting period. The newly introduced tests namely informaSeq and VisibiliT are likely to show double digit growth rate during the forecasting period.

iGATE RESEARCH report titled "Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020" is a 107 page report with 40 Figures and 13 Table. This report analyses the Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume - Top 10 NIPT Test, Major Chromosomal Aneuploidies and their Incidence Rate, Major Deals in the NIPT landscape, NIPT Implementation in HICs and LMICs. Driving factors and Challenges for NIPT market.

The 10 NIPT Test covered in the report has been analyzed from 2 viewpoints:

  • 1. NIPT Test Market Revenue (2012-2020)
  • 2. NIPT Test Volume (2012 - 2020)

The 10 NIPT Test covered in the report are:

  • 1. BambniTest
  • 2. Harmony
  • 3. informaSeq
  • 4. MaterniT21 PLUS
  • 5. NIFTY
  • 6. Panorama
  • 7. PrenaTest
  • 8. Verifi
  • 9. VisibiliT
  • 10. NIPD Test

The Major Chromosomal Aneuploidies and their Incidence Rate Covered in the report are:

  • 1. Down Syndrome
  • 2. Edwards Syndrome
  • 3. Patau Syndrome
  • 4. Turner Syndrome
  • 5. Klinefelter Syndrome
  • 6. Jacobs Syndrome
  • 7. Triple X Syndrome

The report also covers NIPT Implementation in High Income Countries and Low - or- Middle Income Countries. The 3 issues for implementation covered are:

  • 1. Clinical Issues
  • 2. Ethical Issues
  • 3. Legal and Regulatory Issues

Source of Information

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Global Non-Invasive Prenatal Testing Market Analysis (2012 - 2020)

  • 2.1 Global Non-Invasive Prenatal Testing Market and Forecast
  • 2.2 Global Non-Invasive Prenatal Testing Volume and Forecast

3. Global Non-Invasive Prenatal Testing Market Share Analysis (2012 - 2020)

  • 3.1 Global Non-Invasive Prenatal Testing Market Share and Forecast
  • 3.2 Global Non-Invasive Prenatal Testing Volume Share and Forecast

4. Major Chromosomal Aneuploidies and Incidence Rate Analysis

  • 4.1 Down Syndrome
  • 4.2 Edwards Syndrome
  • 4.3 Patau Syndrome
  • 4.4 Turner Syndrome
  • 4.5 Klinefelter Syndrome
  • 4.6 Jacobs Syndrome
  • 4.7 Triple X Syndrome

5. Global Non-Invasive Prenatal Testing - Comparative Tests Analysis

6. Global Non-Invasive Prenatal Testing Market Revenue and Volume - By Test (2012 - 2020)

  • 6.1 Global - Bambni Test Market Revenue and Volume Analysis
    • 6.1.1 Global - Bambni Test Market Revenue and Forecast
    • 6.1.2 Global - Bambni Test Volume and Forecast
  • 6.2 Global - Harmony Prenatal Test Market Revenue and Volume Analysis
    • 6.2.1 Global - Harmony Prenatal Test Market Revenue and Forecast
    • 6.2.2 Global - Harmony Prenatal Test Volume and Forecast
  • 6.3 Global - informaSeq Test Market Revenue and Volume Analysis
    • 6.3.1 Global - informaSeq Test Market Revenue and Forecast
    • 6.3.2 Global - informaSeq Test Volume and Forecast
  • 6.4 Global - MaterniT21 PLUS Test Market Revenue and Volume Analysis
    • 6.4.1 Global - MaterniT21 PLUS Test Market Revenue and Forecast
    • 6.4.2 Global - MaterniT21 PLUS Test Volume and Forecast
  • 6.5 Global - Non-invasive Fetal Trisomy (NIFTY) Test Market Revenue and Volume Analysis
    • 6.5.1 Global - NIFTY Test Market Revenue and Forecast
    • 6.5.2 Global - NIFTY Test Volume and Forecast
  • 6.6 Global - Panorama Prenatal Test Market Revenue and Volume Analysis
    • 6.6.1 Global - Panorama Prenatal Test Market Revenue and Forecast
    • 6.6.2 Global - Panorama Prenatal Test Volume and Forecast
  • 6.7 Global - PrenaTest Market Revenue and Volume Analysis
    • 6.7.1 Global - PrenaTest Market Revenue and Forecast
    • 6.7.2 Global - PrenaTest Volume and Forecast
  • 6.8 Global - Verifi Prenatal Test Market Revenue and Volume Analysis
    • 6.8.1 Global - Verifi Prenatal Test Market Revenue and Forecast
    • 6.8.2 Global - Verifi Prenatal Test Volume and Forecast
  • 6.9 Global - VisibiliT Test Market Revenue and Volume Analysis
    • 6.9.1 Global - VisibiliT Test Market Revenue and Forecast
    • 6.9.2 Global - VisibiliT Test Volume and Forecast
  • 6.10 Global - NIPD Test Market Revenue and Volume Analysis
    • 6.10.1 Global - NIPD Test Market Revenue and Forecast
    • 6.10.2 Global - NIPD Test Volume and Forecast

7. Global Non-Invasive Prenatal Testing Market - Major Deals

  • 7.1 Non-Invasive Prenatal Testing - Collaboration Deals
    • 7.1.1 Year 2007
    • 7.1.2 Year 2013
    • 7.1.3 Year 2015
  • 7.2 Non-Invasive Prenatal Testing - Partnership Deals
    • 7.2.1 Year 2012
    • 7.2.2 Year 2013
    • 7.2.3 Year 2014
    • 7.2.4 Year 2015
  • 7.3 Non-Invasive Prenatal Testing - Distribution Agreement
    • 7.3.1 Year 2012
    • 7.3.2 Year 2013
  • 7.4 Non-Invasive Prenatal Testing - Licensing Agreement
    • 7.4.1 Year 2007
    • 7.4.2 Year 2011
    • 7.4.3 Year 2013
    • 7.4.4 Year 2014
  • 7.5 Non-Invasive Prenatal Testing - Exclusive Agreement
    • 7.5.1 Year 2008
    • 7.5.2 Year 2013
    • 7.5.3 Year 2014
  • 7.6 Non-Invasive Prenatal Testing - Merger and Acquisition
    • 7.6.1 Year 2013
    • 7.6.2 Year 2014
  • 7.7 Non-Invasive Prenatal Testing - Venture Capital Investment
    • 7.7.1 Year 2011
    • 7.7.2 Year 2012
    • 7.7.3 Year 2013

8. Non-Invasive Prenatal Testing (NIPT) Implementation

  • 8.1 Non-Invasive Prenatal Testing (NIPT) Implementation - High-Income Countries
    • 8.1.1 Clinical Issues
    • 8.1.2 Ethical Issues
    • 8.1.3 Legal and Regulatory Issues
  • 8.2 Non-Invasive Prenatal Testing (NIPT) Implementation - Low - or-Middle Income Countries
    • 8.2.1 Clinical Issues
    • 8.2.2 Ethical Issues
    • 8.2.3 Legal and Regulatory Issues

9. Global Non-Invasive Prenatal Testing - Market Drivers

  • 9.1 High Incidence Rate of Babies Born with Down Syndrome
  • 9.2 Rising Average Maternal Age - Increases Risk of Birth Defects

10. Global Non-Invasive Prenatal Testing - Challenges

  • 10.1 Regulatory Guidelines and Ethical Hurdles
  • 10.2 Limitations of NIPT

List of Figures:

  • Figure 2-1: Global - Non-Invasive Prenatal Testing Market (Million US$), 2012 - 2014
  • Figure 2-2: Global - Forecast for Non-Invasive Prenatal Testing Market (Million US$), 2015 - 2020
  • Figure 2-3: Global - Non-Invasive Prenatal Test Volume (Number), 2012 - 2014
  • Figure 2-4: Global - Forecast for Non-Invasive Prenatal Testing Volume (Number), 2015 - 2020
  • Figure 6-1: Global - Bambni Test Market Revenue (Million US$), 2012 - 2014
  • Figure 6-2: Global - Forecast for Bambni Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-3: Global - Bambni Test Volume (Number), 2012 - 2014
  • Figure 6-4: Global - Forecast for Bambni Test Volume (Number), 2015 - 2020
  • Figure 6-5: Global - Harmony Prenatal Test Market Revenue (Million US$), 2012 - 2014
  • Figure 6-6: Global - Forecast for Harmony Prenatal Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-7: Global - Harmony Prenatal Test Volume (Number), 2012 - 2014
  • Figure 6-8: Global - Forecast for Harmony Prenatal Test Volume (Number), 2015 - 2020
  • Figure 6-9: Global - informaSeq Test Market Revenue and Forecast (Million US$), 2014 - 2020
  • Figure 6-10: Global - informaSeq Test Volume and Forecast (Number), 2014 - 2020
  • Figure 6-11: Global - MaterniT21 PLUS Test Market Revenue (Million US$), 2011 - 2014
  • Figure 6-12: Global - Forecast for MaterniT21 PLUS Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-13: Global - MaterniT21 PLUS Test Volume (Number), 2011 - 2014
  • Figure 6-14: Global - Forecast for MaterniT21 PLUS Test Volume (Number), 2015 - 2020
  • Figure 6-15: Global - NIFTY Test Market Revenue (Million US$), 2012 - 2014
  • Figure 6-16: Global - Forecast for NIFTY Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-17: Global - NIFTY Test Volume (Number), 2012 - 2014
  • Figure 6-18: Global - Forecast for NIFTY Test Volume (Number), 2015 - 2020
  • Figure 6-19: Global - Panorama Prenatal Test Market Revenue (Million US$), 2013 - 2014
  • Figure 6-20: Global - Forecast for Panorama Prenatal Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-21: Global - Panorama Prenatal Test Volume (Number), 2013 - 2014
  • Figure 6-22: Global - Forecast for Panorama Prenatal Test Volume (Number), 2015 - 2020
  • Figure 6-23: Global - PrenaTest Market Revenue (Million US$), 2012 - 2014
  • Figure 6-24: Global - Forecast for PrenaTest Market Revenue (Million US$), 2015 - 2020
  • Figure 6-25: Global - PrenaTest Volume (Number), 2012 - 2014
  • Figure 6-26: Global - Forecast for PrenaTest Volume (Number), 2015 - 2020
  • Figure 6-27: Global - Verifi Prenatal Test Market Revenue (Million US$), 2012 - 2014
  • Figure 6-28: Global - Forecast for Verifi Prenatal Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-29: Global - Verifi Prenatal Test Volume (Number), 2012 - 2014
  • Figure 6-30: Global - Forecast for Verifi Prenatal Test Volume (Number), 2015 - 2020
  • Figure 6-31: Global - VisibiliT Test Market Revenue and Forecast (Million US$), 2014 - 2020
  • Figure 6-32: Global - VisibiliT Test Volume and Forecast (Number), 2014 - 2020
  • Figure 6-33: Global - NIPD Test Market Revenue (Million US$), 2013 - 2014
  • Figure 6-34: Global - Forecast for NIPD Test Market Revenue (Million US$), 2015 - 2020
  • Figure 6-35: Global - NIPD Test Volume (Number), 2013 - 2014
  • Figure 6-36: Global - Forecast for NIPD Test Volume (Number), 2015 - 2020

List of Tables:

  • Table 3-1: Global - Non-Invasive Prenatal Testing Market Share (Percent), 2012 - 2014
  • Table 3-2: Global - Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2015 - 2020
  • Table 3-3: Global - Non-Invasive Prenatal Testing Volume Share (Percent), 2012 - 2014
  • Table 3-4: Global - Forecast for Non-Invasive Prenatal Testing Volume Share (Percent), 2015 - 2020
  • Table 5-1: Non-Invasive Prenatal Testing - Comparative Tests Analysis
  • Table 7-1: Non-Invasive Prenatal Testing - Collaboration Deals, 2007 - 2015
  • Table 7-2: Non-Invasive Prenatal Testing - Partnership Deals, 2012 - 2015
  • Table 7-3: Non-Invasive Prenatal Testing - Distribution Agreement, 2012 - 2013
  • Table 7-4: Non-Invasive Prenatal Testing - Licensing Agreement, 2007 - 2014
  • Table 7-5: Non-Invasive Prenatal Testing - Exclusive Agreement, 2008 - 2014
  • Table 7-6: Non-Invasive Prenatal Testing - Merger & Acquisition, 2013 - 2014
  • Table 7-7: Non-Invasive Prenatal Testing - Venture Capital Investment, 2011 - 2013
  • Table 9-1: Global - Age Wise Risk of Birth Defects with Down Syndrome
Back to Top